Clinical Trials Clinical Trials

Alzheimer’s Disease - Agitation/Aggression

Bipolar Disorder

  • ELND005*  More.  

 

* Not approved for said population. Currently under investigation.

Recent News Recent News

05/15/2013: Elan Announces Publication of Response Document More.

05/13/2013: Elan Provides Additional Commentary on Elan/Theravance Royalty Participation Agreement More.

05/13/2013: Theravance and Elan Enter Into a $1.0 Billion Royalty Participation Agreement More.